ArticlePloS one2023
Return(s) on investment: Restoration spending in the Columbia River Basin and increased abundance of salmon and steelhead.
Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Riparian Bryophytes: An Overlooked Yet Important Habitat for Aquatic Macroinvertebrates in Interior Pacific Northwest (USA) Salmonid-Bearing Streams.Ecology and evolution · 2025Article
- Modeling Climate and Hydropower Influences on the Movement Decisions of an Anadromous Species.Global change biology · 2025Article
- Phenotypic Sorting of Pink Salmon Hatchery Strays May Alleviate Adverse Impacts of Reduced Variation in Fitness-Associated Traits.Ecology and evolution · 2025Article
- Salmon hatchery strays can demographically boost wild populations at the cost of diversity: quantitative genetic modelling of Alaska pink salmon.Royal Society open science · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The decline in salmon and steelhead populations in the Columbia River Basin has been well documented, as have the decades-long, $9 billion restoration spending efforts by federal and state agencies. These efforts are mainly tied to Endangered Species Act (ESA) mandates for recovery of wild, naturally-spawning threatened or endangered fish species. The impact of these efforts remains poorly understood; many observers, including the federal courts, have long been concerned by the lack of evidence of recovery. Most studies evaluating restoration efforts have examined individual projects for specific species, reaches, or life stages, which limits the ability to make broad inferences at the basin level. There is a need to ask: is there evidence of an overall increase in wild fish abundance associated with the totality of these recovery efforts? To that end, the current study estimates fixed-effects panel regression models of adult returns of four species. Results indicate that restoration spending combined with hatchery production are associated with substantial increases in returning adult fish. Evidence of benefits to wild fish alone, however, require indirect approaches given the commingling of restoration spending with spending on hatchery releases, the impacts of spending on hatchery fish survival, and the density dependence effects of hatchery releases. To accomplish this, the models' predicted adult returns (both hatchery and wild fish) attributed to both spending and hatchery releases are compared to independent estimates of returning hatchery fish based on hatchery survival estimates (smolt-to-adult ratios). The comparison finds the model-predicted levels of adult returns due to spending and hatchery releases do not exceed the survival-rate based estimates for hatcheries alone, so that we are unable to reject the hypothesis of no benefits to wild fish from the restoration spending.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.